Extracellular cues influencing oligodendrocyte differentiation and (re)myelination
- PMID: 27016069
- PMCID: PMC5010977
- DOI: 10.1016/j.expneurol.2016.03.019
Extracellular cues influencing oligodendrocyte differentiation and (re)myelination
Abstract
There is an increasing number of neurologic disorders found to be associated with loss and/or dysfunction of the CNS myelin sheath, ranging from the classic demyelinating disease, multiple sclerosis, through CNS injury, to neuropsychiatric diseases. The disabling burden of these diseases has sparked a growing interest in gaining a better understanding of the molecular mechanisms regulating the differentiation of the myelinating cells of the CNS, oligodendrocytes (OLGs), and the process of (re)myelination. In this context, the importance of the extracellular milieu is becoming increasingly recognized. Under pathological conditions, changes in inhibitory as well as permissive/promotional cues are thought to lead to an overall extracellular environment that is obstructive for the regeneration of the myelin sheath. Given the general view that remyelination is, even though limited in human, a natural response to demyelination, _targeting pathologically 'dysregulated' extracellular cues and their downstream pathways is regarded as a promising approach toward the enhancement of remyelination by endogenous (or if necessary transplanted) OLG progenitor cells. In this review, we will introduce the extracellular cues that have been implicated in the modulation of (re)myelination. These cues can be soluble, part of the extracellular matrix (ECM) or mediators of cell-cell interactions. Their inhibitory and permissive/promotional roles with regard to remyelination as well as their potential for therapeutic intervention will be discussed.
Keywords: CNS injury; Extracellular; Multiple sclerosis; Myelin; Neuropsychiatric diseases; Oligodendrocyte; Regeneration; Remyelination; Signaling.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15. Adv Exp Med Biol. 1999. PMID: 10635029 Review.
-
Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.J Neurosci. 2017 Aug 2;37(31):7534-7546. doi: 10.1523/JNEUROSCI.3454-16.2017. Epub 2017 Jul 10. J Neurosci. 2017. PMID: 28694334 Free PMC article.
-
Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.J Neurosci. 2018 Feb 14;38(7):1802-1820. doi: 10.1523/JNEUROSCI.1291-17.2018. Epub 2018 Jan 15. J Neurosci. 2018. PMID: 29335358 Free PMC article.
-
Engineering biomaterial microenvironments to promote myelination in the central nervous system.Brain Res Bull. 2019 Oct;152:159-174. doi: 10.1016/j.brainresbull.2019.07.013. Epub 2019 Jul 12. Brain Res Bull. 2019. PMID: 31306690 Review.
-
Mechanisms of remyelination: recent insight from experimental models.Biomol Concepts. 2014 Aug;5(4):289-98. doi: 10.1515/bmc-2014-0015. Biomol Concepts. 2014. PMID: 25372760 Review.
Cited by
-
Lysophosphatidic acid signaling via LPA6 : A negative modulator of developmental oligodendrocyte maturation.J Neurochem. 2022 Dec;163(6):478-499. doi: 10.1111/jnc.15696. Epub 2022 Oct 18. J Neurochem. 2022. PMID: 36153691 Free PMC article.
-
Impact of neonatal hypoxia-ischaemia on oligodendrocyte survival, maturation and myelinating potential.J Cell Mol Med. 2018 Jan;22(1):207-222. doi: 10.1111/jcmm.13309. Epub 2017 Aug 7. J Cell Mol Med. 2018. PMID: 28782169 Free PMC article.
-
Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease.Front Cell Neurosci. 2024 Sep 2;18:1422130. doi: 10.3389/fncel.2024.1422130. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39285941 Free PMC article. Review.
-
DDR1 and Its Ligand, Collagen IV, Are Involved in In Vitro Oligodendrocyte Maturation.Int J Mol Sci. 2023 Jan 16;24(2):1742. doi: 10.3390/ijms24021742. Int J Mol Sci. 2023. PMID: 36675255 Free PMC article.
-
The Extracellular Matrix Proteins Tenascin-C and Tenascin-R Retard Oligodendrocyte Precursor Maturation and Myelin Regeneration in a Cuprizone-Induced Long-Term Demyelination Animal Model.Cells. 2022 May 28;11(11):1773. doi: 10.3390/cells11111773. Cells. 2022. PMID: 35681468 Free PMC article.
References
-
- Abbracchio MP, Burnstock G, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006;58:281–341. - PMC - PubMed
-
- Almeida RG, Lyons DA. On the resemblance of synapse formation and CNS myelination. Neuroscience. 2014;276:98–108. - PubMed
-
- Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, Grinspan JB. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res. 2008;86:125–135. - PubMed
-
- Arellano RO, Sanchez-Gomez MV, Alberdi E, Canedo-Antelo M, Chara JC, Palomino A, Perez-Samartin A, Matute C. Axon-to-Glia Interaction Regulates GabaA Receptor Expression in Oligodendrocytes. Mol Pharmacol. 2015 Nov 4; [Epub ahead of print] - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical